HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elias Campo Selected Research
Elias Campo Research Topics
Disease
82
Neoplasms (Cancer)
01/2024 - 01/2002
41
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2024 - 01/2002
35
Lymphoma (Lymphomas)
03/2024 - 03/2002
29
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2023 - 06/2002
23
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2023 - 09/2002
13
B-Cell Lymphoma (Lymphoma, B Cell)
03/2023 - 06/2004
10
Disease Progression
01/2021 - 11/2004
7
Burkitt Lymphoma (Burkitt's Lymphoma)
01/2016 - 06/2006
6
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2014 - 04/2002
5
Leukemia
01/2018 - 06/2004
5
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018 - 01/2007
4
Trisomy (Trisomies)
12/2021 - 01/2018
4
Genetic Translocation (Chromosomal Translocation)
03/2008 - 01/2005
3
T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 06/2013
3
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 02/2014
3
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2019 - 02/2002
3
Ataxia Telangiectasia (Louis Bar Syndrome)
11/2011 - 01/2002
3
Chromosomal Instability (Chromosome Stability)
10/2008 - 12/2002
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 06/2004
2
Carcinogenesis
01/2024 - 10/2012
2
T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2022 - 01/2020
2
Multiple Myeloma
01/2021 - 01/2020
2
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2017 - 02/2013
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017 - 10/2010
2
Sarcoma (Soft Tissue Sarcoma)
01/2017 - 01/2016
2
Carcinoma (Carcinomatosis)
11/2006 - 11/2005
1
Hematologic Neoplasms (Hematological Malignancy)
05/2024
Drug/Important Bio-Agent (IBA)
32
Proteins (Proteins, Gene)
FDA Link
05/2024 - 01/2002
13
Rituximab (Mabthera)
FDA Link
10/2023 - 01/2011
13
Cyclin D1
IBA
01/2021 - 02/2003
10
Messenger RNA (mRNA)
IBA
01/2017 - 12/2002
9
Biomarkers (Surrogate Marker)
IBA
10/2023 - 03/2007
9
Phosphotransferases (Kinase)
IBA
12/2021 - 01/2002
9
Cyclins
IBA
01/2021 - 12/2005
9
Paraffin
IBA
01/2018 - 10/2008
8
Immunoglobulins (Immunoglobulin)
IBA
01/2023 - 03/2002
7
DNA (Deoxyribonucleic Acid)
IBA
02/2014 - 06/2002
6
MicroRNAs (MicroRNA)
IBA
01/2022 - 09/2008
6
Formaldehyde (Formol)
FDA Link
01/2018 - 06/2011
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2017 - 09/2002
6
Anaplastic Lymphoma Kinase
IBA
05/2014 - 04/2002
5
Chromatin
IBA
01/2021 - 01/2017
5
Antigens
IBA
01/2019 - 02/2002
5
fludarabine
IBA
04/2017 - 09/2002
5
Bortezomib (Velcade)
FDA Link
02/2013 - 01/2006
4
Antibodies
IBA
01/2014 - 03/2002
4
Prednisone (Sone)
FDA Link
Generic
10/2012 - 11/2011
4
Vincristine (Oncovin)
FDA Link
Generic
10/2012 - 11/2011
4
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2012 - 11/2011
4
Cyclin D2
IBA
11/2009 - 02/2004
4
Pyridinolcarbamate (P23)
IBA
01/2005 - 04/2002
3
Bendamustine Hydrochloride
FDA Link
10/2023 - 11/2008
3
ibrutinib
IBA
12/2020 - 09/2015
3
Ligands
IBA
12/2019 - 11/2004
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2019 - 09/2004
3
Transcription Factors (Transcription Factor)
IBA
01/2018 - 06/2009
3
Lenalidomide (CC 5013)
FDA Link
01/2018 - 10/2010
3
Mitoxantrone (Novantrone)
FDA Link
Generic
04/2017 - 09/2002
3
Nucleosides
IBA
08/2015 - 07/2006
3
Cytidine Deaminase
IBA
06/2015 - 07/2006
3
RNA (Ribonucleic Acid)
IBA
02/2014 - 08/2010
3
Proteasome Inhibitors
IBA
11/2011 - 01/2006
3
Immunoglobulin M (IgM)
IBA
01/2010 - 03/2002
3
NF-kappa B (NF-kB)
IBA
04/2009 - 06/2006
3
Nucleophosmin
IBA
01/2005 - 08/2004
2
HLA-B Antigens (HLA-B)
IBA
03/2024 - 03/2023
2
Protein Isoforms (Isoforms)
IBA
12/2022 - 06/2007
2
Cytokines
IBA
12/2021 - 01/2019
2
Chemokines
IBA
12/2021 - 01/2018
2
Agammaglobulinaemia Tyrosine Kinase
IBA
12/2021 - 11/2017
2
venetoclax
IBA
12/2020 - 08/2015
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2020 - 06/2013
2
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
01/2020 - 01/2019
2
Chemokine Receptors
IBA
01/2019 - 01/2017
2
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
01/2019 - 02/2011
2
Elements
IBA
01/2018 - 03/2013
2
Chlorambucil (Leukeran)
FDA Link
06/2017 - 02/2013
2
carboxyl radical (COO-)
IBA
02/2014 - 06/2011
2
Monoclonal Antibodies
IBA
01/2014 - 08/2011
2
SOXC Transcription Factors
IBA
03/2013 - 11/2009
2
Endoplasmic Reticulum Chaperone BiP
IBA
11/2011 - 01/2011
2
Tyrosine (L-Tyrosine)
FDA Link
12/2010 - 08/2004
2
I-kappa B Kinase
IBA
04/2009 - 02/2007
2
Adenosine Monophosphate (AMP)
IBA
10/2008 - 06/2006
2
Antigen Receptors (Antigen Receptor)
IBA
03/2008 - 07/2006
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
07/2006 - 03/2003
2
Complementary DNA (cDNA)
IBA
09/2005 - 01/2004
1
Aspartic Acid (Aspartate)
FDA Link
05/2024
1
triphosphoric acid (triphosphate)
IBA
05/2024
1
CTPase
IBA
05/2024
1
Histidine (L-Histidine)
FDA Link
05/2024
1
Cytarabine (Cytosar-U)
FDA Link
Generic
05/2024
1
Antioxidants
IBA
01/2024
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2024
1
Immune Checkpoint Inhibitors
IBA
11/2023
1
Trihalomethanes
IBA
09/2023
Therapy/Procedure
29
Therapeutics
01/2024 - 02/2003
10
Drug Therapy (Chemotherapy)
01/2019 - 06/2002
2
Precision Medicine
11/2022 - 01/2022
2
Stem Cell Transplantation
06/2006 - 02/2002